Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122052) titled 'Effect of Saccharomyces boulardii on patients with essential tremor' on April 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
Condition:
Essential tremor
Intervention:
Experimental Group:Saccharomyces boulardii sachets: 250 mg/sachet, 2 sachets each time, 3 times daily, orally.
Primidone: 25 mg, once daily, orally.
Experimental Group:Saccharomyces boulardii sachets: 250 mg/sachet, 2 sachets each time, 3 times daily, orally.
Control Group:Inactive bacterial placebo: 0.25 g, three times daily, orally.
Primidone: 25 mg, once da...